<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DB19C118-7DAA-4DDB-ACE8-8F1C22222483"><gtr:id>DB19C118-7DAA-4DDB-ACE8-8F1C22222483</gtr:id><gtr:firstName>Edwin</gtr:firstName><gtr:otherNames>Roy</gtr:otherNames><gtr:surname>Chilvers</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8327D449-2BA3-47AD-9FFE-B041E02AAAC1"><gtr:id>8327D449-2BA3-47AD-9FFE-B041E02AAAC1</gtr:id><gtr:firstName>Charlotte</gtr:firstName><gtr:surname>Summers</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FP502091%2F1"><gtr:id>AB9759E1-6F5E-4AAA-8404-4E6D8D34FDAC</gtr:id><gtr:title>Stratified interventions in ARDS (EMINENT)</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/P502091/1</gtr:grantReference><gtr:abstractText>There is an urgent and unmet need to define disease pathogenesis in acute respiratory distress syndrome (ARDS), and to develop rapid diagnostics to aid patient stratification and support targeted intervention. This is a programmatic approach to define disease pathogenesis in ARDS, and to develop rapid diagnostics to aid patient stratification and support targeted intervention.</gtr:abstractText><gtr:technicalSummary>WP1: ARDS: in whom to intervene? This will involve an unbiased informatics-based analysis of existing (HARP2, REST, MOSAIC, GALAXY, ARDS.NET) and new patient cohorts to define ARDS endotypes

WP2: ARDS: when to intervene? Undertake prospective analysis of trans-pulmonary cytokine, genomic/epigenomic and neutrophil and monocyte phenotyping/migration signatures, and novel imaging modalities (SPECT/CT, PET/CT) to define the optimal time for intervention in the above cohorts, and to develop rapid ('by lunchtime') diagnostic platforms. This WP will specifically test the concepts generated in well-established and highly refined animal, human lung slice and EVLP models of ALI

WP3: ARDS with what to intervene? The collaborative network established above will, together with GSK, be ideally positioned to deliver Phase IIa experimental POC studies, using existing assets in the specific subtypes identified; endpoints (e.g. vascular leak, cell migration, physiological indices, biomarkers) will be determined by the endotype under study</gtr:technicalSummary><gtr:fund><gtr:end>2019-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2017-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>306681</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C1E5433F-4FFB-4E36-AAC7-0E6B59E730FD</gtr:id><gtr:title>Mechanical deformation induces depolarization of neutrophils.</gtr:title><gtr:parentPublicationTitle>Science advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15c0477f7fe725031173f29c6a847837"><gtr:id>15c0477f7fe725031173f29c6a847837</gtr:id><gtr:otherNames>Ekpenyong AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2375-2548</gtr:issn><gtr:outcomeId>5a9523904b6292.25358513</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70535D24-5FC9-433D-9A04-CA388CB467A1</gtr:id><gtr:title>Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cb2ed5d3d9879c33e75413e0566c3b6"><gtr:id>1cb2ed5d3d9879c33e75413e0566c3b6</gtr:id><gtr:otherNames>Proudfoot A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5a952194e02089.40284213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>039A8270-BCA7-4C3E-AFDE-B0AD4E7789A1</gtr:id><gtr:title>The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad05eb8af2eb3ea8a5dd12f4cd23bc6d"><gtr:id>ad05eb8af2eb3ea8a5dd12f4cd23bc6d</gtr:id><gtr:otherNames>Hammond M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a951ff25b8987.16410634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B20FB832-8FD0-40DE-9051-6283A246ADE9</gtr:id><gtr:title>Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolism.</gtr:title><gtr:parentPublicationTitle>Science immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59e42e9d22616597037c27e2e8b3dbf"><gtr:id>a59e42e9d22616597037c27e2e8b3dbf</gtr:id><gtr:otherNames>Thompson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2470-9468</gtr:issn><gtr:outcomeId>58c6a30fed34d5.79584874</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>164C73AA-9857-46D2-AA52-6565627B0865</gtr:id><gtr:title>Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5256cc1eefeee3265036be967c6183b1"><gtr:id>5256cc1eefeee3265036be967c6183b1</gtr:id><gtr:otherNames>Toepfner N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5a95238f634860.84646470</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C53E14EE-70A8-49A4-8F70-30979FA44F6F</gtr:id><gtr:title>Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68750f66e943f97a26162062fd9aa30d"><gtr:id>68750f66e943f97a26162062fd9aa30d</gtr:id><gtr:otherNames>Thomas DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>58e36d371dd953.80107338</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CB2FFD0-C2AB-4120-9A00-BA0071ED6CA7</gtr:id><gtr:title>Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-a-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38325730519fe16b3fc5dda69a444f24"><gtr:id>38325730519fe16b3fc5dda69a444f24</gtr:id><gtr:otherNames>Mitrofan CG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5a952390260419.01996547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9443E45-2148-4FC2-8420-AA5CC0DDF29F</gtr:id><gtr:title>NBEAL2 is required for neutrophil and NK cell function and pathogen defense.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7425737acb342150873cbdd44319c6e9"><gtr:id>7425737acb342150873cbdd44319c6e9</gtr:id><gtr:otherNames>Sowerby JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>5a95238ff09042.20989437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>330ECD34-61C2-4E75-A4BD-0BDE94A485CB</gtr:id><gtr:title>Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes excessive neutrophilic responses.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6007ed87afc2a745b6fcb42abd8d9fee"><gtr:id>6007ed87afc2a745b6fcb42abd8d9fee</gtr:id><gtr:otherNames>Sadiku P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>5a95238fc9d661.76287202</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEF0BB57-42AB-4F92-8308-51A4C3B97B99</gtr:id><gtr:title>Cardiovascular adaptation to hypoxia and the role of peripheral resistance.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bedc97eb00ae94b2e25c0b876eda4add"><gtr:id>bedc97eb00ae94b2e25c0b876eda4add</gtr:id><gtr:otherNames>Cowburn AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5a95238f87cf54.32822863</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFE65416-3902-4FE6-A6AF-C6C733173508</gtr:id><gtr:title>Human Cytomegalovirus Delays Neutrophil Apoptosis and Stimulates the Release of a Prosurvival Secretome.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e3aef83bbb2774fa038f41c1fe6bb0a"><gtr:id>4e3aef83bbb2774fa038f41c1fe6bb0a</gtr:id><gtr:otherNames>Pocock JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a95238faaa6d6.12785025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E385E02F-8FB8-44CF-97CB-D5F2439A5BB8</gtr:id><gtr:title>Identification of LukPQ, a novel, equid-adapted leukocidin of Staphylococcus aureus.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/452da8614deba295e23791bf94be48c6"><gtr:id>452da8614deba295e23791bf94be48c6</gtr:id><gtr:otherNames>Koop G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5889ffa3960927.41990353</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/P502091/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>